CD20 Antikörper (Cytoplasmic) (APC-H7)
Kurzübersicht für CD20 Antikörper (Cytoplasmic) (APC-H7) (ABIN1176878)
Target
Alle CD20 (MS4A1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    - 
                                            Bindungsspezifität
- Cytoplasmic
- 
                                            Marke
- BD Phosflow™
- 
                                            Aufreinigung
- The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
- 
                                            Immunogen
- Human B lymphoma cell line
- 
                                            Isotyp
- IgG2a kappa
 
- 
                                            
- 
    
- 
    - 
                                            Kommentare
- 
                        BALB/c 
- 
                                            Probenmenge
- 5 μL
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- Aqueous buffered solution containing BSA, protein stabilizer, and ≤0.09 % sodium azide.
- 
                                            Konservierungsmittel
- Sodium azide
- 
                                            Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- 4 °C
- 
                                            Informationen zur Lagerung
- Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The antibody was conjugated with APC-H7 under optimum conditions, and unconjugated antibody and APC-H7 were removed.
 
- 
                                            
- 
    - 
                                            : "The biology of CD20 and its potential as a target for mAb therapy."    in: Current directions in autoimmunity, Vol. 8, pp. 140-74, (2004)         (PubMed).        
 
 
- 
                                            : "The biology of CD20 and its potential as a target for mAb therapy."    in: Current directions in autoimmunity, Vol. 8, pp. 140-74, (2004)         (PubMed).        
- 
    - CD20 (MS4A1) (Membrane-Spanning 4-Domains, Subfamily A, Member 1 (MS4A1))
- 
                                            Andere Bezeichnung
- CD20
- 
                                            Hintergrund
- 
                        The H1 (FB1) antibody specificially binds to a cytoplasmic domain of CD20. CD20 is a 33-37-kDa four transmembrane phosphoprotein that is expressed by B lymphocytes from the pre-B stage and most malignant B cells and is lost during plasma cell differentiation. Low level CD20 expression is observed on a subset of normal circulating T lymphocytes, and CD20-positive T-cell lymphomas have been reported. The CD20 molecule is associated with membrane lipid raft domains, acts as a channel for calcium ions, and is involved in the regulation of B cell activation and survival. The cytoplasmic domain regions are serine and threonine rich and contain multiple phosphorylation consensus sequences.
 Synonyms: MS4A1, membrane-spanning 4-domains subfamily A member 1, B1, Bp35, LEU-16
 Target
- 
                    
 
                                     
                                     
                                    